A case report of Coccidioides posadasii meningoencephalitis in an immunocompetent host

BMC Infectious Diseases - Tập 19 - Trang 1-5 - 2019
Raynell Lang1, William Stokes1, Jane Lemaire1, Andrew Johnson1, John Conly1,2
1Department of Medicine, Cumming School of Medicine, University of Calgary and Alberta Health Services, Calgary, Canada
2Departments of Medicine, Microbiology, immunology & Infectious Diseases, Pathology & Laboratory Medicine. Cumming School of Medicine, University of Calgary and Alberta Health Services, Calgary, Canada

Tóm tắt

Coccidioides spp. are dimorphic fungi endemic to Central America, regions of South America and southwestern USA. Two species cause most human disease: Coccidioides immitis (primarily California isolates) and Coccidioides posadasii. Coccidioidomycosis is typically acquired through inhalation of soil or dust containing spores. Coccidioidal meningitis (CM), most common in the immunocompromised host, can also affect immunocompetent hosts. We report a case of C. posadasii meningoencephalitis in a previously healthy 42-year-old Caucasian male who returned to Canada after spending time working in New Mexico. He presented with a 3-week history of headache, malaise and low-grade fevers. He developed progressive confusion and decreasing level of consciousness following hospitalization. Evidence of hydrocephalus and leptomeningeal enhancement was demonstrated on magnetic resonance imaging (MRI) of his brain. Serologic and PCR testing of the patient's CSF confirmed Coccidioides posadasii. Despite appropriate antifungal therapy he continues to have significant short-term memory deficits and has not returned to his full baseline functional status. Travel to endemic regions can result in disease secondary to Coccidioides spp. and requires physicians in non-endemic areas to have a high index of suspicion. Effective therapeutic options have reduced the mortality rate of CM, however, it is still associated with significant morbidity and requires life-long therapy.

Tài liệu tham khảo

Kirkland TN, Fierer J. Coccidioides immitis and posadasii; a review of their biology, genomics, pathogenesis, and host immunity. Virulence. 2018;9(1):1426–35. Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Geertsma F, Hoover SE, et al. 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of Coccidioidomycosis. Clin Infect Dis. 2016;63(6):e112–46. Johnson R, Ho J, Fowler P, Heidari A. Coccidioidal meningitis: a review on diagnosis, treatment, and management of complications. Curr Neurol Neurosci Rep. 2018;18(4):19. Tan LA, Kasliwal MK, Nag S, O'Toole JE, Traynelis VC. Rapidly progressive quadriparesis heralding disseminated coccidioidomycosis in an immunocompetent patient. J Clin Neurosci. 2014;21(6):1049–51. Johnson L, Gaab EM, Sanchez J, Bui PQ, Nobile CJ, Hoyer KK, et al. Valley fever: danger lurking in a dust cloud. Microbes Infect. 2014;16(8):591–600. Whiston E, Taylor JW. Genomics in Coccidioides: insights into evolution, ecology, and pathogenesis. Med Mycol. 2014;52(2):149–55. Stockamp NW, Thompson GR 3rd. Coccidioidomycosis. Infect Dis Clin N Am. 2016;30(1):229–46. Blair JE, Logan JL. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis. 2001;33(9):1536–44. Nelson JK, Giraldeau G, Montoya JG, Deresinski S, Ho DY, Pham M. Donor-derived Coccidioides immitis endocarditis and disseminated infection in the setting of solid organ transplantation. Open Forum Infect Dis. 2016;3(3):ofw086. Assi MA, Binnicker MJ, Wengenack NL, Deziel PJ, Badley AD. Disseminated coccidioidomycosis in a liver transplant recipient with negative serology: use of polymerase chain reaction. Liver Transpl. 2006;12(8):1290–2. Ho J, Fowler P, Heidari A, Johnson RH. Intrathecal amphotericin B: a 60-year experience in treating Coccidioidal meningitis. Clin Infect Dis. 2017;64(4):519–24. Drake KW, Adam RD. Coccidioidal meningitis and brain abscesses: analysis of 71 cases at a referral center. Neurology. 2009;73(21):1780–6. Ismail Y, Arsura EL. Eosinophilic meningitis associated with coccidioidomycosis. West J Med. 1993;158(3):300–1. Sawanyawisuth K, Chotmongkol V. Eosinophilic meningitis. Handb Clin Neurol. 2013;114:207–15. Lo Re V 3rd, Gluckman SJ. Eosinophilic meningitis. Am J Med. 2003;114(3):217–23. Bamberger DM, Pepito BS, Proia LA, Ostrosky-Zeichner L, Ashraf M, Marty F, et al. Cerebrospinal fluid Coccidioides antigen testing in the diagnosis and management of central nervous system coccidioidomycosis. Mycoses. 2015;58(10):598–602. Stevens DA, Zhang Y, Finkelman MA, Pappagianis D, Clemons KV, Martinez M. Cerebrospinal fluid (1,3)-Beta-d-glucan testing is useful in diagnosis of Coccidioidal meningitis. J Clin Microbiol. 2016;54(11):2707–10. Nelson S, Vytopil M. Recurrence of coccidioidal meningitis after discontinuation of fluconazole. JAMA Neurol. 2013;70(12):1586. Pappas PG, Kauffman CA, Perfect J, Johnson PC, McKinsey DS, Bamberger DM, et al. Alopecia associated with fluconazole therapy. Ann Intern Med. 1995;123(5):354–7.